UCSF

ZINC03786466

Substance Information

In ZINC since Heavy atoms Benign functionality
September 26th, 2005 22 No

Other Names:

(6aR,9R)-9-((Methylthio)methyl)-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline

(6aR,9R,10aR)-9-(Methylthiomethyl)-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline

(8beta)-8-[(methylsulfanyl)methyl]-6-propylergoline

(8beta)-8-[(methylthio)methyl]-6-propylergoline

erg-

66104-22-1

66104-22-1; C07425; Pergolide

66104-22-1; D08339; Pergolide (INN); Permax (TN)

66104-23-2 (mesylate)

66104-23-2; D00502; Pergolide mesilate (JAN); Pergolide mesylate (USP); Permax (TN)

66104-23-2; Pergolide mesylate; Prestwick_652

8-beta-((Methylthio)methyl)-6-propylergoline methanesulfonate; 8-beta-((Methylthio)methyl)-6-propylergoline monomethane sulfonate; 8beta-((Methylthio)methyl)-6-propylergoline monomethanesulfonate; C19H26N2S.CH4O3S; Ergoline, 8-((methylthio)methyl)-6-propy

8beta-[(Methylthio)methyl]-6-propylergoline methanesulfonate salt

AC1L2IT3

AC1Q7DT2

BIDD:GT0177

Biomol-NT_000025

BPBio1_000254

BPBio1_001211

BRD-K60770992-001-01-8

BRD-K60770992-066-05-2

BSPBio_000230

BSPBio_003156

C07425

C19H26N2S

Celance

CHEBI:112494

CHEBI:8020

CHEMBL531

CID47811

CPD000058504

CPD000058504; PERGOLIDE MESYLATE SALT; SAM001247070

CPD000058504; Pergolide mesylate; SAM001247070

D08339

DAP000069

DB01186

DivK1c_000442

Ergoline, 8-((methylthio)methyl)-6-propyl-, (8beta)-

FDA)

HMS2089C18

IDI1_000442

InChI=1/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3/t13-,16-,18-/m1/s

INN); Pergolide Mesylate (FDA

INN); Pergolide Mesylate (USAN

KBio1_000442

KBio2_002127

KBio2_004695

KBio2_007263

KBio3_002656

KBioGR_001409

KBioSS_002127

LS-187145

LS-64479

LY-127,809

LY-127809

LY-141-B

MFCD00153859

MolPort-003-849-834

N/A

NCGC00017366-05

NCGC00142538-01

NCGC00142538-02

NCGC00142538-03

nchembio873-comp45

NINDS_000442

Nopar

Parkotil

Pergolida

Pergolida [INN-Spanish]

Pergolida [INN-Spanish];Pergolide Methanesulfonate;Pergolidum [INN-Latin]

Pergolida

pergolida; pergolide; pergolidum

Pergolide

Pergolide (BAN

Pergolide (INN)

Pergolide mesylate salt

Pergolide Methanesulfonate

Pergolide [INN:BAN]

pergolide(1+)

Pergolidum

Pergolidum [INN-Latin]

Pergotoliderived

Permax

Permax (TN)

Pharken

Prestwick0_000295

Prestwick1_000295

Prestwick2_000295

Prestwick3_000295

SPBio_002099

SPBio_002449

Spectrum2_001970

Spectrum3_001588

Spectrum4_000835

Spectrum5_001649

Spectrum_001647

ST057534

UNII-24MJ822NZ9

USAN

USP

USP)

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.97 11.27 -39.66 2 2 1 20 315.506 4
Hi High (pH 8-9.5) 3.97 9.08 -5.67 1 2 0 19 314.498 4

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 5.84e-04 g/l DrugBank-withdrawn
mechanism Agonist at the dopamine D2, D1 and serotonin 5-HT(1A), 5-HT(1B), 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptors IBScreen Bioactives
biological_use Also used for veterinary purposes. IBScreen Bioactives
Target Dopamine Receptor Selleck Chemicals
therap dopamine receptor agonist MicroSource Spectrum
Therapy Dopamine receptor agonist; antiparkinsonian SMDC Iconix
PUBCHEM_PATENT_ID EP0026671A1; EP0185491A1; EP0314387A1; EP0314387B1; US4166182; US4180582; US4202979; US4246265; US4675322; US4683313; US4782152; US4797405; US4801712; US5114948; US5416090; WO2000044748A1 IBM Patent Data
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 101757; 1 methanesulfonic acid NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 101757; SALT: 1 methanesulfonic acid NIH Clinical Collection via PubChem
biological_use Used to treat various conditions including Parkinson's disease, hyperprolactinemia, and restless leg syndrome. IBScreen Bioactives

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
DRD1-1-E Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 50 0.46 Binding ≤ 10μM
DRD3-1-E Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic Eukaryotes 70 0.46 Binding ≤ 10μM
DRD4-3-E Dopamine D4 Receptor (cluster #3 Of 4), Eukaryotic Eukaryotes 70 0.46 Binding ≤ 10μM
DRD5-1-E Dopamine D5 Receptor (cluster #1 Of 1), Eukaryotic Eukaryotes 70 0.46 Binding ≤ 10μM
Z50425-3-O Plasmodium Falciparum (cluster #3 Of 22), Other Other 7943 0.32 Functional ≤ 10μM
Z50597-1-O Rattus Norvegicus (cluster #1 Of 12), Other Other 0 0.00 Functional ≤ 10μM
DRD2-23-E Dopamine D2 Receptor (cluster #23 Of 24), Eukaryotic Eukaryotes 70 0.46 Binding ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
DRD1_RAT P18901 Dopamine D1 Receptor, Rat 70 0.46 Binding ≤ 1μM
DRD1_BOVIN Q95136 Dopamine D1 Receptor, Bovin 50 0.46 Binding ≤ 1μM
DRD2_RAT P61169 Dopamine D2 Receptor, Rat 70 0.46 Binding ≤ 1μM
DRD2_BOVIN P20288 Dopamine D2 Receptor, Bovin 50 0.46 Binding ≤ 1μM
DRD3_RAT P19020 Dopamine D3 Receptor, Rat 70 0.46 Binding ≤ 1μM
DRD4_RAT P30729 Dopamine D4 Receptor, Rat 70 0.46 Binding ≤ 1μM
DRD5_RAT P25115 Dopamine D5 Receptor, Rat 70 0.46 Binding ≤ 1μM
DRD1_BOVIN Q95136 Dopamine D1 Receptor, Bovin 50 0.46 Binding ≤ 10μM
DRD1_RAT P18901 Dopamine D1 Receptor, Rat 70 0.46 Binding ≤ 10μM
DRD2_RAT P61169 Dopamine D2 Receptor, Rat 70 0.46 Binding ≤ 10μM
DRD2_BOVIN P20288 Dopamine D2 Receptor, Bovin 50 0.46 Binding ≤ 10μM
DRD3_RAT P19020 Dopamine D3 Receptor, Rat 70 0.46 Binding ≤ 10μM
DRD4_RAT P30729 Dopamine D4 Receptor, Rat 70 0.46 Binding ≤ 10μM
DRD5_RAT P25115 Dopamine D5 Receptor, Rat 70 0.46 Binding ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 3981.07171 0.34 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 0.1 0.64 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Dopamine receptors
G alpha (i) signalling events
G alpha (s) signalling events

Analogs ( Draw Identity 99% 90% 80% 70% )